Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s selection of charts is FTSE 100, Bitcoin, Artemis, Boku, Audioboom,

Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s selection of charts is FTSE 100, Bitcoin, Artemis, Boku, Audioboom,
Overall, AIM’s top shares enjoyed a good week. The junior market 100 indexes rose 0.5% in the past five days to 4,386. This was compared to a flat Footsie performance.
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s selection of charts is FTSE 100, Bitcoin, Bushveld, DeepVerge, Galileo,
Poolbeg Pharma (POLB), a clinical-stage infectious disease pharmaceutical company, said it has received ethics and competent authority approval to commence its Lipopolysaccharide human challenge clinical trial for POLB 001, which
Canadian Overseas Petroleum (COPL) announced an extension to the previously announced Purchase Agreement to acquire the United States assets of Cuda Energy LLC.
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s selection of charts is FTSE 100, Bitcoin, Arrow, Aston, Cyanconnode,
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s selection of charts is FTSE 100, Bitcoin, Aston Martin, Bens,
“Stocks aren’t lottery tickets. Behind every stock is a company. If the company does well, over time the stocks do well, and vice versa. You have to look at the
Eurasia Mining (EUA), the precious metals producing company reported its audited financial results and operational summary. The company said that operationally the West Kytlim asset is performing well following a
Poolbeg Pharma (POLB), a clinical-stage infectious disease pharmaceutical company, said that AI partner OneThree Biotech, Inc., has completed the build and optimisation of a tailored AI model of Poolbeg’s RSV
Genflow (LSE: GENF) is pleased to announce it has entered into a research agreement with Magnitude Biosciences Limited (“Magnitude”), a UK-based, specialist biotechnology research organisation that supports drug discovery and